Romina Quercia, MD, PhD, MGH

Biography

Global Executive Medical Affairs Lead, Doctor in Medicine, Infectious Disease Specialist and Doctor in Molecular Virology. Master in Global Health. Experienced in all stages of antiviral drugs development cycle and clinical research phases. Strong background in Pharmaceutical Industry with 15 years of experienced in Medical Affairs, particularly in extremely challenging and dynamic projects. Hospital ID Consultant with a vast network within the medical and scientific international community, as well as patient care

Romina is Doctor in Medicine graduated in Buenos Aires University with Infectious Disease Certification in 2003

Fellow In HIV/AIDS – Centre of Excellence in HIV/AIDS – Univ British Columbia- Vancouver 2002

Fellowship in ID, College of Physicians, Paris France- 2004

PhD, in Molecular Virology in antiviral resistance at the Sorbonne University- Pierre and Marie Curie- Paris VI-2009

Master in Global Health & Global Health Delivery, Harvard University, 2018

She joined Pfizer in 2021 to lead SARS CoV-2 mRNA vaccines and then became Global Medical Lead in Antivirals

She started her Industry experience in 2009 in Gilead Science where she was instrumental in development and launch of several HIV, HBV and HCV antivirals, from 2014 to 2020 she continues research and medical leading positions in ViiV Healthcare.

When the SARS CoV-2 Pandemic started she joined a task force group for Covid-19 in GSK and then Pfizer, since then she continues to work in Pandemic preparedness and antiviral new targets.

 

 

Romina Quercia, 2023
Position
Pfizer, United Kingdom